reca 1 (Proteintech)
Proteintech is a verified supplier 
94
Structured Review
Proteintech
reca 1
Reca 1, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 3 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rad51/RAD51+Fusion+Protein/pmc12972984-356-25-23
Average 94 stars, based on 3 article reviews
Reca 1, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 3 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rad51/RAD51+Fusion+Protein/pmc12972984-356-25-23
Average 94 stars, based on 3 article reviews
reca 1 - by Bioz Stars,
2026-09
94/100 stars
Images
1) Product Images from "Targeting VEGFR2 inhibition within a spatially-confined conduit promotes nerve self-resolution and alleviates mechanical allodynia"
Article Title: Targeting VEGFR2 inhibition within a spatially-confined conduit promotes nerve self-resolution and alleviates mechanical allodynia
Journal: Bioactive Materials
doi: 10.1016/j.bioactmat.2026.03.009
Figure Legend Snippet: Prevention of neuroma formation by a spatially confined conduit filled with GelMA MAVP MPS. ( A ) Illustration of 3D-printed GelMA MPs loaded with MAVP and the proposed mechanism of action within the neural conduit. ( B ) Representative images and ( C ) quantitative scores of autotomy behavior over 12 weeks (n = 6). ( D ) Representative gait footprints at 12 weeks post-surgery. ( E ) Quantification of left hindlimb stance duration (n = 6) and ( F ) maximum contact area (n = 6). ( G ) IF staining of p-VEGFR2 activation and ( H ) IF staining of neovascularization marker RECA-1. (I) Quantification of p-VEGFR2-positive area percentage (n = 6). and ( J ) quantification of RECA-1-positive area percentage (n = 6). ( K ) Regenerated nerve length measurements (n = 6). Mean values are shown and error bars represent ± s.d., as analyzed by one-way ANOVA followed by the Tukey-Kramer test in ( C , E , F , I , J and K ). Biological replicates were used for all experiments. ns, p > 0.05, ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001.
Techniques Used: Staining, Activation Assay, Marker
Related Articles
Incubation:Article Title: Homoisoflavanone Delays Colorectal Cancer Progression via DNA Damage‐Induced Mitochondrial Apoptosis and Parthanatos‐Like Cell Death Article Snippet: .. The membranes were then blocked with a 5% non‐fat milk TBST (TBS containing 0.1% Tween‐20) for 1 h at room temperature and incubated at 4°C for overnight with primary antibodies against the following proteins: cleaved Caspase 3 (25128‐1‐AP, Proteintech), cleaved Caspase 8 (9496, CST), PARP (9542, CST), cleaved PARP (9541, CST), P21 (2947, CST), P53 (2527, CST), Cyclin A2 (91500, CST), Cyclin D1 (2978, CST), CDK1 (bs‐1341R, Bioss), CDK2 (bs‐10726R, Bioss), CDK7 (bs‐0569R, Bioss), AKT (4691, CST), p‐AKT (4060, CST), ERK (9102, CST), p‐ERK (9101, CST), MEK (9126, CST), p‐MEK (9154, CST), ATR (13934, CST), p‐ATR (2853, CST), Chk1 (2360, CST), p‐Chk1 (2348, CST), Article Title: Multi-target modulation of the homologous recombination pathway by resveratrol promotes DNA damage repair in POI: integrated network pharmacology, molecular dynamics simulation, and experimental validation Article Snippet: .. After incubation with primary antibodies against γH2AX and Article Title: Multi-target modulation of the homologous recombination pathway by resveratrol promotes DNA damage repair in POI: integrated network pharmacology, molecular dynamics simulation, and experimental validation Article Snippet: .. The sections were then incubated overnight at 4°C with primary antibodies against ATM, BRCA1, and Article Title: Homoisoflavanone Delays Colorectal Cancer Progression via DNA Damage-Induced Mitochondrial Apoptosis and Parthanatos-Like Cell Death. Article Snippet: .. The membranes were then blocked with a 5% non-fat milk TBST (TBS containing 0.1% Tween-20) for 1 h at room temperature and incubated at 4◦C for overnight with primary antibodies against the following proteins: cleaved Caspase 3 (25128-1-AP, Proteintech), cleaved Caspase 8 (9496, CST), PARP (9542, CST), cleaved PARP (9541, CST), P21 (2947, CST), P53 (2527, CST), Cyclin A2 (91500, CST), Cyclin D1 (2978, CST), CDK1 (bs-1341R, Bioss), CDK2 (bs-10726R, Bioss), CDK7 (bs-0569R, Bioss), AKT (4691, CST), p-AKT (4060, CST), ERK (9102, CST), p-ERK (9101, CST), MEK (9126, CST), p-MEK (9154, CST), ATR (13934, CST), p-ATR (2853, CST), Chk1 (2360, CST), p-Chk1 (2348, CST), other:Article Title: USP5-mediated CD73 deubiquitination drives osimertinib resistance via PI3K/AKT and glycolysis activation in LUAD Article Snippet: |
